Discover
WHWK
Whitehawk Therapeutics Inc
4.76
1 x 4.62
1 x 4.95
bid
ask
+
0.06
1.28%
undefined @ 04:00 PM
4.67 -0.09 (1.89%)
| Ytd | 96.69% | |
| 1y | 176.74% |
4.59
day range
4.88
1.60
52 week range
5.10
| Open | 4.69 | Prev Close | 4.70 | Low | 4.59 | High | 4.88 | Mkt Cap | 235.39M |
| Vol | 600.06K | Avg Vol | 528.54K | EPS | -1.12 | P/E | -4.25 | Forward P/E | N/A |
| Beta | 0.76 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.14 | 200-d Avg | 3.32 | 1yr Est | 0.00 |
WHWK News
prnewswire.com
Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
Phase 1 trials for HWK-007 and HWK-016 continue to enroll; the Phase 1 trial for HWK-206 is on track
benzinga.com
Leerink Partners Initiates Coverage On Whitehawk Therapeutics with Outperform Rating, Announces Pric
Leerink Partners analyst Jonathan Chang initiates coverage on Whitehawk Therapeutics (NASDAQ:WHWK